Adam S. Grossman
2021
In 2021, Adam S. Grossman earned a total compensation of $4.4M as Director, President and Chief Executive Officer at ADMA Biologics, a 122% increase compared to previous year.
Compensation breakdown
| Bonus | $731,142 |
|---|---|
| Option Awards | $673,859 |
| Salary | $618,000 |
| Stock Awards | $2,294,903 |
| Other | $43,346 |
| Total | $4,361,250 |
Grossman received $2.3M in stock awards, accounting for 53% of the total pay in 2021.
Grossman also received $731.1K in bonus, $673.9K in option awards, $618K in salary and $43.3K in other compensation.
Rankings
In 2021, Adam S. Grossman's compensation ranked 3,037th out of 12,415 executives tracked by ExecPay. In other words, Grossman earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,037 out of 12,415 | 76th |
Division Manufacturing | 1,213 out of 5,505 | 78th |
Major group Chemicals And Allied Products | 486 out of 2,375 | 80th |
Industry group Drugs | 429 out of 2,096 | 80th |
Industry Biological Products, Except Diagnostic Substances | 120 out of 449 | 73rd |
Source: SEC filing on April 28, 2022.
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2021.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019